Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice

Kidney International

Volumn 52, Issue 1, 1997, Pages 52-59

  Kitching, A Richard ^a   Tipping, Peter G ^b   Huang, Xiao Ru ^b   Mutch, David A ^b   Holdsworth, Stephen R ^b  

^a MONASH UNIVERSITY   (Australia)

^b NONE

Author keywords

Crescentic glomerulonephritis; Delayed type hypersensitivity; Interleukin; Macrophage; T cell

Indexed keywords

RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; GLOMERULONEPHRITIS; HISTOPATHOLOGY; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030762688     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.303     Document Type: Article

References (47)

1. BOLTON WK, INNES DJ JR, STURGILL BC, KAISER DL: T-cells and macrophages in rapidly progressive glomerulonephritis: Clinicopathologic correlations. Kidney Int 32:869-876, 1987
2. NEALE TJ, TIPPING PG, CARSON SD, HOLDSWORTH SR: Participation of cell-mediated immunity in deposition of fibrin in glomerulonephritis. Lancet 2:421-424, 1988
3. HUANG XR, HOLDSWORTM SR, TIPPING PG: Evidence for delayed type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int 46:69-78, 1994
4. HUANG XR, TIPPING PG, LI S, HOLDSWORTH SR: Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int 51:94-103, 1997
5. STILMANI MM, BOLTON WK, STURGILL BC, COUSER WG: Crescentic glomerulonephritis without immune deposits: Clinicopathologic features. Kidney Int 15:184-195, 1979
6. BOLTON WK, TUCKER FL, STURGILL, BC: New avian model of experimental glomerulonephritis consistent with mediation by cellular immunity. Nonhumorally mediated glomerulonephritis in chickens. J Clin Invest 73:1263-1276, 1984
7. LI S, HOLDSWORTH SR, TIPPING PG: Antibody independent crescentic glomerulonephritis in μ chain deficient mice. Kidney Int 51:672-678, 1997
8. MOSMANN TR, CHERWINSKI H, BOND MW, GIEDLIN MA, COFFMAN RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348-2357, 1986
9. ROMAGNANI S: Biology of human TH1 and TH2 cells. J Clin Immunol 15:121-129, 1995
10. CHER DJ, MOSMANN TR: Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol 138:3688-3694, 1987
11. MOSMANN TR, COFFMAN RL: TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173, 1989
12. REINER SL, LOCKSLEY RM: The regulation of immunity to Leishmania major. Annu Rev Immunol 181:1251-1254, 1995
13. MOSMANN TR, SAD S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146, 1996
14. LEONARD JP, WALDBURGER KE, GOLDMAN SJ: Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med 181:381-386, 1995
15. ANGUITA J, PERSING DH, RINCON M, BARTHOLD SW, FIKRIG E: Effect of anti-interleukin 12 treatment on murine lyme borreliosis. J Clin Invest 97:1028-1034, 1996
16. POWRIE F, MENON S, COFFMAN RL: Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 23:2223-2229, 1993
17. RACKE MK, BONOMO A, SCOTT DE, CANNELLA B, LEVINI A, RAINE CS, SHEVACH EM, ROCKEN M: Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180:1961-1966, 1994
18. MIGNON-GODEFROY K, ROTT O, BRAZILLET MP, CHARREIRE J: Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT). Evidence for IL-10-enhanced cell death in EAT. J Immunol 154:6634-6643, 1995
19. KELLY JP, BANCROFT GJ: Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes. Eur J immunol 26:356-364, 1996
20. TONNETTI L, SPACCAPELO R, CENCI E, MENCACCI A, PUCCETTI P, COFFMAN RL, BISTONI F, ROMANI L: Interleukin-4 and -10 exacerbate candidiasis in mice. Eur J Immunol 25:1559-1565, 1995
21. ROCKEN M, SHEVACH EM: Immune deviation - The third dimension of nondeletional T cell tolerance. Immunol Rev 149:175-194, 1996
22. TIPPING PG, KITCHING AR, HUANG XR, MUTCH DA, HOLDSWORTH SR: Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol 27:530-537, 1997
23. TIPPING PG, HUANG XR, BERNDT MC, HOLDSWORTH SR: A role for P selectin in complement-independent neutrophil-mediated glomerular injury. Kidney Int 46:79-88, 1994
24. TIPPING PG, HUANG XR, BERNDT MC, HOLDSWORTH SR: P-selectin directs T lymphocyte mediated injury in delayed type hypersensitivity responses: Studies in glomerulonephritis and cutaneous delayed type hypersensitivity. Eur J Immunol 26:454-460, 1996
25. BRADFORD MM: A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
26. RABINOVITCH A, SUAREZ-PINZON WL, SORENSEN O, BLEACKLEY RC, POWER RF, RAJOTTE RV: Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice. Analysis of cytokine mRNA expression in the graft. Transplantation 60:368-374, 1995
27. HOLDSWORTH SR, NEALE TJ, WILSON CB: Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit. Use of an antimacrophage serum. J Clin Invest 68:686-698, 1981
28. TIPPING PG, LOWE MG, HOLDSWORTH SR: Glomerular macrophages express augmented procoagulant activity in experimental fibrin-related glomerulonephritis in rabbits. J Clin Invest 82:1253-1259, 1988
29. TIPPING PG, DOWLING JP, HOLDSWORTH SR: Glomerular procoagulant activity in human proliferative glomerulonephritis. J Clin Invest 81:119-125, 1988
30. NAISH P, PENN GB, EVANS DJ, PETERS DK: The effect of defibrination on nephrotoxic serum nephritis in rabbits. Clin Sci 42:643-646, 1972
31. FIORENTINO DF, ZLOTNIK A, VIEIRA P, MOSMANN TR, HOWARD M, MOORE KW, O'GARRA A: IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444-3451, 1991
32. BOGDAN C, VODOVOTZ Y, NATHAN C: Macrophage deactivation by interleukin 10. J Exp Med 174:1549-1555, 1991
33. FIORENTINO DF, ZLOTNIK A, MOSMANN TR, HOWARD M, O'GARRA A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822, 1991
34. TIPPING PG, LEONG TW, HOLDSWORTH SR: Tumor necrosis factor production by glomerular macrophages in anti- glomerular basement membrane glomerulonephritis in rabbits. Lab Invest 65:272-279, 1991
35. TIPPING PG, LOWE MG, HOLDSWORTH SR: Glomerular interleukin 1 production is dependent on macrophage infiltration in anti-GBM glomerulonephritis. Kidney Int 39:103-110, 1991
36. LAN HY, NIKOLIC-PATERSON DJ, ZARAMA M, VANNICE JL, ATKINS RC: Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. Kidney Int 43:479-485, 1993
37. GAUTAM S, TEBO JM, HAMILTON TA: IL-4 suppresses cytokine gene expression induced by IFN-gamma and/or IL-2 in murine peritoneal macrophages. J Immunol 148:1725-1730, 1992
38. APPELBERG R, ORME IM, PINTO DE SOUSA MI, SILVA MT: In vitro effects of interleukin-4 on interferon-gamma-induced macrophage activation. Immunology 76:553-559, 1992
39. TAN HP, NEHLSEN-CANNARELLA SL, GARBEROGLIO CA, TOSK JM: Recombinant interleukin-4 enhances the chemiluminescent oxidative burst of murine peritoneal macrophages. J Leuk Biol 49:587-591, 1991
40. PHILLIPS WA, CROATTO M, HAMILTON JA: Priming the macrophage respiratory burst with IL-4: Enhancement with TNF-alpha hut inhibition by IFN-gamma. Immunology 70:498-503, 1990
41. NAKAZATO Y, OKADA H, SATO A, IWAITA Y, HAYASHIDA T, HAYASHI M, SUZUKI H, SARUTA T: Interleukin 4 downregulates cell growth and prostaglandin release of human mesangial cells. Biochem Biophvs Res Commun 197:486-493, 1993
42. FOUQUERAY B, BOUTARD V, PHILIPPE C, KORNREICH A, MARCHANT A, PEREZ J, GOLDMAN M, BAUD L: Mesangial cell-derived interleukin-10 modulates mesangial cell response to lipopolysaccharide. Am J Pathol 147:176-182, 1995
43. DAI Z, LI X, WANG H: Interleukin-10 inhibits interleukin-1 stimulated pro-inflammatory responses in cultured rat mesangial cells. (abstract) J Am Soc Nephrol 7:1696, 1996
44. HUANG XR, TIPPING P, HOLDSWORTH S: Th2 T helper cell responses to glomerular antigens induce acute humorally mediated injury in anti-GBM glomerulonephritis in mice. (abstract) J Am Soc Nephrol 7:1704, 1996
45. ISHIDA H, MUCHAMUEL T, SAKAGUCHI S, ANDRADE S, MENON S, HOWARD M: Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179:305-310, 1994
46. JACOB CO, VAN DEN MEIDE PH, MCDEVITT HO: In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to γ interferon. J Exp Med 166:798-803, 1987
47. TAKAHASHI S, FOSSATI L, IWAMOTO M, MERINO R, MOTTA R, KOBAYAKAWA T, IZUI S: Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 97:1597-1604, 1996